Late of Sunday, Emergent BioSolutions Inc said, a key U.S. agency has increased an order related to the manufacturing of Johnson & Johnson’s COVID-19 vaccine, by $23 million. “The amount will be used to purchase biologics equipment specific to J&J’s… Read More ›
On Wednesday, in a statement Pfizer Inc said, it has decided to stop producing biosimilar products in China; it has also decided to sell one of its business unit in the eastern city of Hangzhou to WuXi Biologics Inc. “The… Read More ›
According to a report from The Times, AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion. Moderna’s shares soared following news of its COVID-19 vaccine breakthrough. The report did not clarify the period over… Read More ›
In a statement, Brazil’s health ministry said, it will be signing a non-binding letters of intent to buy coronavirus vaccines from four companies as well as from Russia’s sovereign wealth fund; these purchases will be subject to the approval of… Read More ›
The deal sees Britain’s AstraZeneca Plc led by Pascal Soriot sharing development and commercialization costs for the drug worldwide. For AstraZeneca the deal makes sense as it will replenish its pipeline as its cancer drug sales grow. In a significant… Read More ›
manageria.biz 